REVIEW
Published on 22 Apr 2024
The C1q and gC1qR axis as a novel checkpoint inhibitor in cancer
doi 10.3389/fimmu.2024.1351656
- 2,248 views
- 3 citations
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Role of gC1qR/p32/HABP1 in Anti-tumoral Immunity and Immune Response Against Pathogens
Role of gC1qR/p32/HABP1 in Anti-tumoral Immunity and Immune Response Against Pathogens
5,497
Total downloads
15k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 02 Jun 2023
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma
doi 10.3389/fimmu.2023.1151194
- 3,078 views
- 2 citations
MINI REVIEW
Published on 26 Jan 2023
gC1qR: A New Target for Cancer Immunotherapy
doi 10.3389/fimmu.2023.1095943
- 3,300 views
- 7 citations
ORIGINAL RESEARCH
Published on 31 Aug 2021
HCV Core Protein Induces Chemokine CCL2 and CXCL10 Expression Through NF-κB Signaling Pathway in Macrophages
doi 10.3389/fimmu.2021.654998
- 2,957 views
- 15 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 15kTopic views
- 9,230Article views
- 5,497Article downloads